Carrier risk assessment for Duchenne muscular dystrophy (DMD) is necessary to counsel women at risks of developing cardiomyopathy and having a child with DMD. Comprehensive molecular testing for dystrophin gene mutations has only been available since 20031; women counseled earlier have outdated risk assessments. We present a 5-generation family in whom results of familial mutation testing for DMD newly identified 10 obligate carriers and 28 women at risk to be carriers for DMD.
Outdated risk assessment in a family with Duchenne dystrophy: Implications for duty to reassess
Published 2016 in Neurology: Genetics
ABSTRACT
PUBLICATION RECORD
- Publication year
2016
- Venue
Neurology: Genetics
- Publication date
2016-10-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-7 of 7 references · Page 1 of 1
CITED BY
Showing 1-4 of 4 citing papers · Page 1 of 1